This assignment is an analysis of a selected neuropsychological disorder. The disorder you select this week will be used to complete the Week 1 assignment (topic selection). You will continue to use the same disorder to complete the Week 2 assignment (elaboration on pharmacological management of the same disorder), and the Week 6 assignment (comprehensive Critical Review of the same disorder and its management).

Your completed Week 1 and Week 2 assignments will be used as a foundation to help you complete your Week 6 assignment (Critical Review) on the same disorder. Thus, your work in Week 1 and in Week 2 will be used to support your work in Week 6.

Select a neuropsychological disorder  from the following list. Your selection of topic should be based on your personal or professional experience, or your own academic or personal interest in the topic. Be sure to use current terminology from the American Psychiatric Association’s (2013) Diagnostic and Statistical Manual 5 (DSM-5) if this disorder is discussed in that resource. Please note that Substance Use Disorder (SUD) (drug abuse, substance abuse) is not the emphasis of the course. Critical Reviews focusing on SUD or drugs of addiction will not be accepted.

Please select your topic from the following list:

• Schizophrenia
• Major depressive disorder
• Bipolar disorder
• Anxiety disorder
  • Choose and focus on one of the anxiety disorders (g., generalized anxiety disorder or social anxiety disorder).
• Post-traumatic stress disorder (PTSD)
• Obsessive-compulsive disorder (OCD)
• Neurodevelopmental disorder
  • Choose and focus on one of the neurodevelopmental disorders (e.g., autism spectrum disorder or attention-deficit hyperactivity disorder)
• Personality disorder
  • Choose and focus on one of the personality disorders (e.g., borderline personality disorder).
• Neurocognitive disorder
  • Choose and focus on one of the neurocognitive disorders (e.g., one of the dementias).
• Neurological disorder
  • Choose and focus on one neurological disorder (e.g., multiple sclerosis, spina bifida, seizure disorder, Parkinson’s disease or any other movement disorder, chronic pain, traumatic brain injury or other acute brain injury, stroke, infectious brain pathology such as meningitis or encephalitis, migraine headache).
• Other neuropsychological disorder found in the DSM-5 (American Psychiatric Association, 2013) but not on the list above
  • This option must be approved in advance by the instructor before your assignment is submitted.

In keeping with the focus of this class, the emphasis of your paper should be on the neurobiology of the disorder and the related drug treatment that is used in clinical management. Other modes of treatment are not the focus of our class.  For instance, papers that discuss psychotherapy, other than in passing, will not be given credit.  This week, please focus on the neurobiology of the disorder (in Week 2, you will continue to elaborate on the disorder from the perspective of drug treatment). In your paper, please be sure that the following aspects of your topic are discussed:

• Explain the theories of etiology (causes) with a focus on the neurobiology of the disorder (the pathology of the disorder with an emphasis on the abnormalities of nervous system structures and function, including those neurotransmitter systems involved).
• Describe the symptomatology of the disorder and its relationship with the neurotransmitters involved.
• Discuss any anatomical changes seen with this disorder, and explain the relationship between such changes and the symptoms seen in the disorder.
• Close your paper with a summary how the dysregulation of neurotransmitter(s) and any anatomical changes would explain the physical signs and behavioral symptoms displayed by the individual diagnosed with this disorder

Please research your topic and obtain a minimum three scholarly and/or peer-reviewed sources published within the last 5 to 10 years. These sources should provide evidence-based information to help support your analysis, focusing on the aspects described above. Be sure to cite your sources in your paper and include them on your References page. You may utilize required or recommended course materials in your work, but these will not count towards the reference requirements; however, you may cite and reference the American Psychiatric Association’s (2013) DSM-5 as one of your sources used for the grading credit.

The paper:

• Must be three to five double-spaced pages in length (not including title and references pages) and formatted according to APA style as outlined in the Writing Center.Links to an external site.
• Must include a separate title page with the following:
  • Title of paper
  • Student’s name
  • Course name and number
  • Instructor’s name
  • Date submitted
• Must use at least three peer-reviewed sources or scholarly sources published within the last 5 to 10 years. You may utilize required or recommended course materials in your work, but these will not count towards the reference requirements; however, you may cite and reference the American Psychiatric Association’s (2013) DSM-5 as one of your sources used for the grading credit.
• Must document all sources in APA style as outlined in the Writing Center.
• Must include a separate references page that is formatted according to APA style as outlined in the Writing Center.

Carefully review the Grading RubricLinks to an external site. for the criteria that will be used to evaluate your assignment.

Select a psychoactive drug that is of pharmacological interest to you, but not one you will review as part of your Critical Review. For this paper, you may choose drugs of abuse; however, the paper must focus on the pharmacology of the drug and not on the social or addictive aspects. If you focus on addiction and social impact, your paper will not receive credit.

In addition to the text, research a minimum of three peer-reviewed articles published within the last 5 years on your selected drug. Prepare a three-page summary of the drug using the PSY630 Rapid Review Example paper as a guide.

In your Rapid Review, analyze and explain the pharmacological aspects of the drug as they relate to the following: neurotransmitters affected, receptors, route of administration, half-life, doses, side effects, drug interactions, contraindications, and other important facets of the drug. Explain these aspects of the drug in terms of the psychiatric disorders indicated for the drug and the issue(s) associated with that use. If there is no accepted therapeutic use for the drug, evaluate and describe the actions of the drug with regard to the abuse process.

The paper:

• Must be three to five double-spaced pages in length, excluding title page and references page, and it must be formatted according to APA style as outlined in the Writing Center.
• Must include a title page with the following:
  • Title of paper
  • Your name
  • Course name and number
  • Your instructor’s name
  • Date submitted
• Must address the topic of the paper with critical thought.
• Must use at least three peer-reviewed sources in addition to the text.
• Must document all sources in APA style as outlined in the Writing Center.
• Must include a separate references page that is formatted according to APA style as outlined in the Writing Center.

This assignment continues your analysis of your selected neuropsychological disorder. The disorder is the same disorder you selected in Week 1 and for which you discussed its neurobiology in the Week 1 assignment (topic selection). Please remember – you will continue to use the same disorder to complete the Week 6 assignment (comprehensive Critical Review of the same disorder and its management).

Reminder – your completed Week 1 and Week 2 assignments will be used as a foundation to help you complete your Week 6 assignment (Critical Review) on the same disorder. Thus, your work in Week 1 and in Week 2 will be used to support your work in Week 6.

This week, please focus on the pharmacological (drug) treatment of your selected disorder. Other modes of treatment are not the focus of our class. For instance, papers that discuss psychotherapy, other than in passing, will not be given credit. In your paper, please be sure that the following aspects of your topic are discussed:

• Describe the key classes of drugs used to treat your selected disorder. A “class” of drug usually indicates the drug’s mechanism of action (how the drug exerts is pharmacological effects on the body). Be sure to explain why this class of drugs or classes of drugs would be helpful in treating your selected disorder by describing the action of these drugs on the neurotransmitter system(s) involved in the disease process. Within each class of drug, there will be one or more drugs available on the market for use in clinical management, and examples of these should be included in your discussion.
• Analyze and describe the agonist-antagonist activity of the drugs, and the receptor types and subtypes on which the drugs will exert their pharmacological action. Indicate if these drugs will reverse or slow the disease process, or if they will only help ameliorate symptoms.
• Close your paper with an analysis of the risk-benefit of drug use for your selected disorder. Include a discussion of how the drug class(es) would be typically used, what expected benefits would be obtained from drug use, and what common drug side effects might occur.

For Week 2, please research a minimum of three peer-reviewed or scholarly articles published within the last 5 to 10 years. These references are in addition to those used in the Week 1 written assignment and should focus on pharmacological (drug) treatment of your selected disorder. These sources should provide evidence-based information to help support your analysis, focusing on the aspects described above. Be sure to cite your sources in your paper and include them on your References page. You may utilize required or recommended course materials in your work, but these will not count towards the reference requirements; however, you may cite and reference the American Psychiatric Association’s (2013) DSM-5 as one of your sources used for the grading credit.

Prior to beginning work on this discussion, read the required chapters from the text and review the required articles for this week. Humans have engaged in psychoactive drug use, sometimes in formal (ceremonial) settings and sometimes recreationally, since before recorded history. It has only been in the last century or so that abuse and addiction have become large-scale problems. Using the literature and your own insights into these issues, formulate an argument as to why the problem has reached its current scale.  In your discussion, evaluate the employment of psychoactive drugs from the aspects of a risk-benefits analysis and ethical considerations such as the risk of addiction versus the cost of punitive action. Also explain purely pharmacological issues such as pharmacokinetics and routes of drug administration and dose. If needed, include factors such as supply, cultural attitudes to drug use, and the context of drug use.

Passing score: 75%

1.Which of these options is NOT a sharing and scheduling method for dashboards? Please choose the best answer.Schedule delivery.Share via URL.Send.None of the suggested options are sharing and scheduling methods for dashboards.

2.Which of these options is NOT a sharing and scheduling method for Looks? Please choose the best answer.Send.Schedule.Share.Pin to a board.

3.What is the minimum number of numeric measures or table calculations in a tile’s visualization needed to support a tile-level dashboard alert? Please choose the best answer.Three (3).Two (2).One (1).Zero (0).

4.All end users can see and follow all tile-level dashboard alerts if they so choose.FalseTrue

5.End users can download a dashboard to their local computer as .csv, .zip, .pdf or .png file formats.FalseTrue

6.End users can download a Look to their local computer as .csv, .zip, .pdf or .png file formats.FalseTrue